Navigation Links
LSUHSC's Weiss chosen to help set national eye policy, research

New Orleans, LA Kathleen Sebelius, Secretary of the United States Department of Health and Human Services, has invited Jayne S. Weiss, MD, Professor and Chair of the Department of Ophthalmology, Herbert E. Kaufman, MD Endowed Chair in Ophthalmology, and Director of LSU Eye Center of Excellence at LSU Health Sciences Center New Orleans, to serve on the National Advisory Eye Council. Effective immediately, she will serve a four-year term. Dr. Weiss is among the 12 members chosen in the United States, and the only member from Louisiana.

According to the National Eye Institute (one of the institutes of the National Institutes of Health), the Council advises, assists, consults with, and makes recommendations to the Secretary of Health and Human Services and the Director of the National Eye Institute (NEI) on matters related to the activities carried out by and through the NEI and the policies respecting these activities. The Council may review applications for grants and cooperative agreements for research and training and recommend approval of applications for projects which show promise of making valuable contributions to human knowledge; may review any grant, contract, or cooperative agreement proposed to be made or entered into by the Institute; may collect, by correspondence or by personal investigation, information as to studies which are being carried on in the United States or any other country and, with the approval of the Director of NEI, make available such information through appropriate publications for the benefit of public and private health entities, health professions personnel and scientists, and for the information of the general public.

A native of New York City, New York, Dr. Weiss graduated from State University of Buffalo summa cum laude with a 4.0 average and was elected to Phi Beta Kappa. She received her Doctor of Medicine degree from Mt. Sinai Medical School in 1979 and was elected to Alpha Omega Alpha, the medical honor society. She completed her residency training in ophthalmology at the Bascom Palmer Eye Institute, University of Miami School of Medicine in 1983 followed by a fellowship in ocular pathology at Massachusetts Eye and Ear Infirmary, Harvard Medical School in Boston and a fellowship in cornea and external eye diseases at Emory University in Atlanta.

Dr. Weiss was Visiting Professor at Tri Service General Hospital in Taipei, Taiwan in 1985 and Fulbright Professor at Godfrey Huggins School of Medicine in Harare Zimbabwe in 1986. She subsequently served as Assistant Professor and Associate Professor in the Department of Ophthalmology at University of Massachusetts Medical Center from 1986 to 1995. She joined Kresge Eye Institute, the Department of Ophthalmology at Wayne State University in 1995 and left in 2011 as Professor of Ophthalmology and Pathology, and Director of Refractive Surgery, when LSU Health Sciences Center New Orleans recruited her.

Dr. Weiss' principal clinical and research interests are corneal and external diseases, refractive surgery, and corneal dystrophies. Her interest in Schnyder's dystrophy spans 18 years during which time she has studied the clinical findings, visual prognosis and discovered the causative gene for this disease.

Dr. Weiss was Chair of the FDA Ophthalmic Devices Panel, Chair of the American Academy of Ophthalmology Basic and Clinical Sciences Courses (13 books) ,Chair of the American Academy of Ophthalmology Basic and Clinic Sciences Course on Refractive Surgery and edited its first book on Refractive Surgery and Scientific Program Director of the Eye Bank Association of America. She was Acting Chair for the April 2008 FDA meeting on LASIK.

She has been a member of the Basic and Clinical Sciences Course on Cornea and External Eye Diseases, member of NIH Visual Sciences Study Section, Eye Bank Association Research Committee, Preferred Practice Plan for Cornea and External Eye Diseases and the Eye Bank Committee of the American Academy of Ophthalmology, member of the Board of Directors of the Cornea Society and member of the Medical Advisory Board of the Eye Bank Association of America.

Dr. Weiss has received the Service Advisory Award from the FDA and two Secretariat Awards from the American Academy of Ophthalmology. She presently is Chair of the International Committee for Classification of the Corneal Dystrophies, consultant to the FDA Ophthalmic Devices Panel, and a member of the editorial boards of Cornea journal. She has authored 90 articles and chapters.


Contact: Leslie Capo
Louisiana State University Health Sciences Center

Related biology news :

1. GW Research chosen as paper of the week for blood coagulation discovery
2. Story tips From the Department of Energys Oak Ridge National Laboratory, March 2012
3. Ultracold matter technology from CU and SRI International licensed to Boulders ColdQuanta
4. International Polar Year conference: From knowledge to action
5. ASBMB wins National Science Foundation grant to enhance K-12 science education
6. President, CEO Leppävuori, VTT: Finland should create a national bioeconomy strategy
7. Russia declares Land of the Leopard National Park
8. Large international study finds memory in adults impacted by versions of 4 genes
9. International team uncovers new genes that shape brain size, intelligence
10. As deadly cat disease spreads nationally, MU veterinarian finds effective treatment
11. Southampton researchers lead 2 international projects to help people out of poverty
Post Your Comments:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Neurocrine Biosciences, will be presenting at the 27th Annual ... . .   Listeners ... prior to the presentation to download or install any ... available on the website approximately one hour after the ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015 ... that management will participate in a fireside chat discussion ... New York . The discussion is ... Time. .  A replay will ... Contact:  Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate ...
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
(Date:11/24/2015)... DIEGO , Nov. 24, 2015 Halozyme Therapeutics, Inc. ... Healthcare Conference in New York on Wednesday, ... Helen Torley , president and CEO, will provide a corporate ... New York at 1:00 p.m. ET/10:00 a.m. PT ... and investor relations, will provide a corporate overview. --> ...
Breaking Biology Technology: